Abbott Laboratories (ABT) Debt Ratio (2009 - 2026)

Abbott Laboratories (ABT) posted Debt Ratio of 0.3 for Q2 2026, down 3.16% sequentially from 0.31 in Q1 2026, and up 86.64% YoY from 0.16 in Q2 2025.

Abbott Laboratories (ABT) Debt Ratio (2009 - 2026) Analysis & Trends

Abbott Laboratories has reported Debt Ratio for 18 years, with the latest figure at 0.3 in Q2 2026.

Quarterly Debt Ratio rose 86.64% year-over-year to 0.3 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.3 (up 86.64% YoY) and the FY2025 annual result came in at 0.15, down 22.31% from the prior year.
Debt Ratio fell to 0.3 in Q2 2026 per ABT's latest filing, from 0.31 in the prior quarter.
Over five years, Debt Ratio peaked at 0.85 in Q4 2022 and troughed at 0.15 in Q4 2025.
A 5-year average of 0.25 and a median of 0.22 in 2023 frame the typical range for Debt Ratio.
The sharpest annual moves came in 2023 and 2026: Debt Ratio slumped 74.73% in 2023, then soared 89.64% in 2026.
Over 5 years, Debt Ratio stood at 0.85 in 2022, then plunged by 74.73% to 0.22 in 2023, then retreated by 10.84% to 0.19 in 2024, then slipped by 22.31% to 0.15 in 2025, then jumped by 100.24% to 0.3 in 2026.
According to Business Quant data, Debt Ratio over the past three periods registered 0.3, 0.31, and 0.15 for Q2 2026, Q1 2026, and Q4 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	199.24 Bn	193.64 Bn	7.27 Bn	0.30
2	Stryker	128.63 Bn	125.15 Bn	4.50 Bn	0.31
3	Medtronic	119.19 Bn	109.97 Bn	6.41 Bn	0.30
4	Boston Scientific	73.51 Bn	72.97 Bn	3.85 Bn	0.28
5	Edwards Lifesciences	52.11 Bn	47.85 Bn	1.35 Bn	0.04
6	Dexcom	34.64 Bn	32.70 Bn	830.00 Mn	-
7	GE HealthCare Technologies	34.01 Bn	31.90 Bn	2.18 Bn	0.27
8	Koninklijke Philips	26.40 Bn	23.08 Bn	4.55 Bn	0.28
9	Steris	23.14 Bn	22.65 Bn	684.20 Mn	0.18
10	Zimmer Biomet Holdings	19.32 Bn	18.91 Bn	1.54 Bn	0.33

Download Data